Kala Pharmaceuticals Announces Proposed Public Offering of Common Stock by Seini Moimoi | Mar 9, 2020 | Portfolio News
Tricida Hires Robert McKague as Executive Vice President, General Counsel & Chief Compliance Officer by Seini Moimoi | Mar 9, 2020 | Portfolio News
Kala Pharmaceuticals Announces Statistically Significant Results For Primary and Key Secondary Endpoints in Stride 3 Clinical Trial Evaluating Eysuvis™ For Signs and Symptoms of Dry Eye Disease by Seini Moimoi | Mar 9, 2020 | Portfolio News
Amunix Raises $73 Million in Series A Financing Led by Omega Funds by Seini Moimoi | Mar 4, 2020 | Portfolio News
Axonics® Announces Fourth Quarter and Fiscal 2019 Financial Results by Seini Moimoi | Mar 4, 2020 | Portfolio News
